Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

Abstract

The risk of developing endometrial cancer is increased after long-term use of estrogens without progestins and with cyclically added progestins. Continuously added progestins may be needed to minimize the endometrial cancer risk associated with estrogen replacement therapy.